Deals - Page 14

Skadden, Weil shepherd Honeywell’s $1.9bn CAES acquisition

Weil counsels seller Advent as Skadden acts for longtime client Honeywell in deal for defence tech company

  • 2yrs

Kirkland, Ropes & Gray steer Bain’s $5.6bn PowerSchool acquisition

Kirkland acts for longtime client PowerSchool as private equity-led deals show signs of picking up

  • 2yrs

Raft of firms called in for Waste Management’s $7.2bn Stericycle acquisition

Latham & Watkins, Hogan Lovells, Vinson & Elkins and Baker Botts steer deal to expand top US waste management company’s healthcare footprint

  • 2yrs

Kirkland, Latham lead on Champion’s $1.2bn sale to Authentic Brands

Kirkland acts for seller HanesBrands alongside Jones Day as Latham counsels Authentic

  • 2yrs

Latham, Orrick lead on SAP’s $1.5bn WalkMe acquisition

Israeli firms Meitar and Gornitzky & Co called in on deal to buy Israeli-founded SaaS company

  • 2yrs

Wachtell, Kirkland lead on ConocoPhillips’ $22.5bn Marathon Oil acquisition

Wachtell guides ConocoPhillips as Kirkland counsels Marathon in latest energy industry mega deal

  • 2yrs

Cleary, DLA Piper and Sidley lead on T-Mobile’s $4.4bn buy of US Cellular’s wireless operations

Clifford Chance, Cravath and Washington DC boutique Wilkinson Barker Knauer also act in deal that will bring T-Mobile four million new customers

  • 2yrs

Paul Hastings, Freshfields and Addleshaws lead on Coventry Building Society’s £780m Co-op Bank acquisition

Deal to create lender with £89bn balance sheet and nearly five million customers

  • 2yrs

Complex global M&A deals face increased merger clearance challenges, study finds

Some 43% of cross-border transactions over the past four years failed to close due to regulatory scrutiny

  • 2yrs

Goodwin, Covington shepherd Biogen’s $1.8bn acquisition of rare disease drugmaker

Covington counsels Biogen as Goodwin reps acquisition target Human Immunobiology Biosciences

  • 2yrs

Latham, Kirkland shepherd CyberArk’s $1.5bn Venafi acquisition

Latham guides CyberArk in acquisition of cybersecurity business from Kirkland-repped Thoma Bravo

  • 2yrs

Latham, Skadden and Paul Weiss among firms advising on $6.9bn Squarespace take private


Private equity firm Permira is leading the deal, with support from General Atlantic and Accel

  • 2yrs

Greenberg, Goodwin shepherd Ono Pharma’s $2.4bn Deciphera acquisition

Greenberg counsels Ono in deal to expand Japanese group’s oncology portfolio and US presence

  • 2yrs

Kirkland, Latham shepherd Thoma Bravo’s £4.3bn Darktrace acquisition

Kirkland acts for marquee client Thoma Bravo as Latham counsels UK-listed cyber security company

  • 2yrs

Reed Smith, Shoosmiths lead on Concord’s £1.1bn Hipgnosis takeover

DLA Piper and Latham also called in for deal to save embattled song fund

  • 2yrs
Top